false
OasisLMS
Catalog
ASGE Postgraduate Course at ACG 2022: Expanding th ...
NEJM: Nordic-European Initiative on Colorectal Can ...
NEJM: Nordic-European Initiative on Colorectal Cancer (NordICC) trial report: An ASGE Update and Response
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
This video features Brett Peterson, the president of ASGE, discussing the Nordic trial on screening colonoscopy. The trial compared the effectiveness of colonoscopy versus usual care for screening colorectal cancer. The study found that there was a reduction in colorectal cancer incidence and mortality at 10 years in the screened group, but the results did not reach statistical significance. However, the media focused on the headline that screening procedure fails to prevent cancer, leading to concerns among patients. Peterson raised concerns about the study's methodology, including low uptake and early analysis. He emphasized that colonoscopy remains an accurate means of detecting and treating colorectal neoplasia. The ASGE has cautioned against changes in current screening practices.
Asset Subtitle
Bret Petersen, MD, MASGE
Keywords
Brett Peterson
ASGE
Nordic trial
screening colonoscopy
colorectal cancer
×
Please select your language
1
English